Synonym
LH2−051; LH2 051; LH2051
IUPAC/Chemical Name
1-(2-(1H-indol-3-yl)ethyl)-6,7-dimethoxy-2-((tetrahydro-2H-pyran-4-yl)methyl)-1,2,3,4-tetrahydroisoquinoline
InChi Key
WBEFXEHFEBYZEJ-UHFFFAOYSA-N
InChi Code
InChI=1S/C27H34N2O3/c1-30-26-15-20-9-12-29(18-19-10-13-32-14-11-19)25(23(20)16-27(26)31-2)8-7-21-17-28-24-6-4-3-5-22(21)24/h3-6,15-17,19,25,28H,7-14,18H2,1-2H3
SMILES Code
COC1=C(C=C(C(CCC2=CNC3=C2C=CC=C3)N(CC4CCOCC4)CC5)C5=C1)OC
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
434.58
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Yin L, Zhou Y, Liu H, Li Y. LYECs: lysosome-enhancing compounds as potential
therapeutic approaches for Alzheimer disease. Autophagy. 2023
Jun;19(6):1863-1864. doi: 10.1080/15548627.2022.2131247. Epub 2022 Oct 10. PMID:
36215390; PMCID: PMC10262797.
2: Yin L, Zhou J, Li T, Wang X, Xue W, Zhang J, Lin L, Wang N, Kang X, Zhou Y,
Liu H, Li Y. Inhibition of the dopamine transporter promotes lysosome biogenesis
and ameliorates Alzheimer's disease-like symptoms in mice. Alzheimers Dement.
2023 Apr;19(4):1343-1357. doi: 10.1002/alz.12776. Epub 2022 Sep 21. PMID:
36130073.
3: Zhou J, Wang N, Wang M, Hu Y, Zhang Z, Gu Z, Wang J, Shou H, Cheng X, Liu H,
Li Y, Zhou Y. Discovery and Optimization of Tetrahydroisoquinoline Derivatives
To Enhance Lysosome Biogenesis as Preclinical Candidates for the Treatment of
Alzheimer's Disease. J Med Chem. 2024 Jun 3. doi: 10.1021/acs.jmedchem.4c00159.
Epub ahead of print. PMID: 38830007.